Moderna Kids Vaccine Review Will Be Unaffected by Pfizer Timing

The FDA will proceed with reviewing Moderna Inc.'s request to authorize its Covid-19 shot for the nation’s youngest children even as a similar vaccine from Pfizer Inc. faces delays, the agency’s head confirmed.

Moderna announced Thursday it applied for emergency use authorization for its Covid-19 vaccine in children from 6 months to under 6 years old. There have been reports that the Food and Drug Administration would wait to authorize Moderna’s under 6 vaccine and Pfizer-BioNTech’s vaccine for children under 5 at the same time, potentially pushing the availability of these vaccines to early summer.

“Most of the experts that ...